First Trust Capital Management L.P. Horizon Therapeutics Public LTD CO Transaction History

First Trust Capital Management L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$98.98 - $115.74 $80.3 Million - $93.9 Million	811,053 Added 1702.21%	858,700 $99.3 Million
Q2 2023 Aug 14, 2023	SELL	$96.34 - $112.38 $50.3 Million - $58.7 Million	-522,032 Reduced 91.64%	47,647 $4.9 Million
Q1 2023 May 12, 2023	BUY	$107.32 - $113.5 $20.8 Million - $22 Million	194,086 Added 51.67%	569,679 $62.2 Million
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $23.4 Million - $42.7 Million	375,593 New	375,593 $42.7 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of First Trust Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on First Trust Capital Management L.P. with notifications on news.